Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 570.00 829,923 15:35:14
Bid Price Offer Price High Price Low Price Open Price
569.50 571.00 597.50 567.50 597.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 504.30 22.60 10.30 55.3 758
Last Trade Time Trade Type Trade Size Trade Price Currency
15:53:07 O 268 568.618 GBX

Clinigen (CLIN) Latest News (1)

More Clinigen News
Clinigen Investors    Clinigen Takeover Rumours

Clinigen (CLIN) Discussions and Chat

Clinigen Forums and Chat

Date Time Title Posts
22/10/202014:58Clinigen - Speciality Pharmaceuticals1,007
24/9/202021:34Clinigen - solid looking growth stock108

Add a New Thread

Clinigen (CLIN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Clinigen trades in real-time

Clinigen (CLIN) Top Chat Posts

DateSubject
25/10/2020
08:20
Clinigen Daily Update: Clinigen Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker CLIN. The last closing price for Clinigen was 570p.
Clinigen Group Plc has a 4 week average price of 567.50p and a 12 week average price of 567.50p.
The 1 year high share price is 1,000p while the 1 year low share price is currently 350.40p.
There are currently 132,898,771 shares in issue and the average daily traded volume is 580,372 shares. The market capitalisation of Clinigen Group Plc is £757,522,994.70.
29/9/2020
06:53
molatovkid: Excellent news this morning.....should light the price up
26/9/2020
16:41
adamb1978: Very quiet on this board, particularly given results were last week. My view on teh results is that they were in-line with what I was expecting, and guidance is similar to management had given before - 5%-10% medium term growth p.a. though with year to Jun-21 at the lower end of that range. Balance sheet is still more levered than I would like, however it was expected to be levered this year and reducing from mid-year to a sensible 1x-2x net debt/ebitda in 12- 18 months. Given the cashflow from the business, there doesnt seem too much risk at all with this happening. Therefore given the rather paltry 10x PE compared to historically trading in the 15x range, I think this remains a solid hold for me. Might not rocket up but I think this has potential to get to £12 per share in a 2-3 years (15x * 80p EPS).
24/9/2020
08:08
adorling: When does CLIN go ex-dividend?
16/9/2020
07:45
bennya: Share price drifted recently, hoping for a good set of results tomorrow to get this back on track. GLA
21/7/2020
20:46
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion covers CLIN which I hold myself. We also chatted about loads of other Stocks and as always a fair bit of general Portfolio Management educational stuff. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 27) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-27-covid19-vaccine-hopes-azn-clin-ipf-vtu-auto-sfor-mpac-net
14/7/2020
13:26
adamb1978: Hi Fernagx Agreed that the leverage is weighing on the price at the moment. I've generally steered clear of levered companies recently but took the plunge with CLIN given that there seems to be a working cap unwind next year(counteracting the working cap increase this year) which will reduce it a bit, along with natural cash generation and which should more than offset the consideration due in the next 12 months. At that point, I'd see it re-rating to the previous multiple levels which I referred to above ADam
14/7/2020
11:24
fernagx: I do think that 11% is a bit of an overreaction. Covid-19 should have already been built into the share price and the Directors have been clear on the trading conditions expected that lie ahead. It will be better to wait until we get full results. If things continue as they are and Covid 19 eases somewhat I expect a return to £8/share. They really need to focus on reducing their debt. Gearing is high.
14/7/2020
06:52
adamb1978: Solid trading statement this morning which underpins the investment case in my view. Decent top-line and profit growth and re-iterating their intention to take leverage down over the next 12-18 months via organic means. Still believe that these are very cheap. Historically they've traded on a 15x-20x PE and based on EPS in 65p-70 range today growing to the 90s over 2-3 years, I dont think its unreasonable to expect the share price to be able to get to the £15 area in that time-frame. Very happy continuing to hold
22/6/2020
20:17
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a Twin Petes Investing Podcast a few days ago and part of our discussion covers CLIN which I hold myself and see as still undervalued. We also chatted about loads of other Stocks and as always a fair bit of general Portfolio Management educational stuff. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 25) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-mobilepayments-bgo-boku-bids-botb-boo-inl-ncyt-itm-clin-mbh
16/3/2020
12:31
fernagx: Completely agree with AdamB1978. CLIN is such a highly cash generative company. They will be relatively resistant to the coronavirus too unlike other businesses and sectors. The current decrease in share price is just the market rather than specifics about CLIN. I too have spread my average. I won't be looking to withdraw my holding until 2030+ though
Clinigen share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CLIN
Clinigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201026 04:38:41